Managing the metabolic side effects of antipsychotic drugs
Dopamine stimulators may lessen the systemic side effects — often weight gain and diabetes — of dopamine-blocking antipsychotics.
Articles by Luisa Torres, PhD
A new major player in T cell suppression and tumor control
An inhibitory receptor binds a checkpoint protein to thwart T cell proliferation and function.
Velcro-like antibiotic may inform new antibiotic design
Plectasin forms dense structures on bacterial membranes by binding to unique lipids in bacterial cell walls.
The Bristol Myers Squibb approach to toxicology
Clinical trial insights refine early-stage toxicology evaluations, yielding safer medicines.
A new pathway to cell death
Cancer cells with mutated p53 undergo apoptosis by stalling ribosomes at rare leucine codons, inhibiting protein translation.
Circular RNA: a new era in therapeutics
The durability and capacity to boost protein expression of circular RNA makes it a promising candidate for next-generation vaccines and gene therapies.
What we know about reversing prediabetes
Lifestyle and genetics intertwine to shape individual risk and the pathway to prediabetes reversal.
From wildlife to bedside: Nature’s wisdom meets modern medicine
Inspired by nature, Peel Therapeutics scientists look to evolution to find the next life changing drug.
Nanobody technology combats deadly snake bites
Antibodies that are a fraction of the size of a regular antibody protect against key toxins in snake venom and could potentially replace 130-year-old treatments.
Why anti-inflammatory treatments fail in rheumatoid arthritis
In rheumatoid arthritis, damaged joints contain fibroblasts that prompt nerve cell growth, potentially causing pain even in the absence of inflammation.
